THE CODI Co.,LTD. (KOSDAQ: 224060)

Market Cap	19.36B
Revenue (ttm)	26.74B
Net Income (ttm)	-6.88B
Shares Out	4.72M
EPS (ttm)	-1,494.41
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	229,165
Open	5,090.00
Previous Close	5,140.00
Day's Range	3,960.00 - 5,180.00
52-Week Range	3,960.00 - 12,510.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About THE CODI Co.,LTD.

THE CODI Co.,LTD. manufactures and sells semiconductor and display equipment, exposure equipment, and bio-healthcare products. It develops therapeutic agent for various diseases, such as Zika/MERS, glaucoma, non-alcoholic fatty liver, and chronic kidney diseases, as well as immunotherapy to treat cancer and inflammatory diseases. The company was formerly known as CODI-M Co., LTD. and changed its name to THE CODI Co.,LTD. in November 2022. THE CODI Co.,LTD. was founded in 1999 and is headquartered in Cheonan-si, South Korea.

• Industry: Special Industry Machinery, not elsewhere classified
• Founded: 1999
• Employees: 45
• Stock Exchange: KOSDAQ
• Ticker Symbol: 224060

Financial Performance

In 2023, THE CODI Co.,LTD.'s revenue was 20.21 billion, an increase of 0.50% compared to the previous year's 20.11 billion. Losses were -7.98 billion, -43.45% less than in 2022.